Synthesis and biological evaluation of a new set of pyrazolo[1,5-c]quinazolines as glycine/N-methyl-D-aspartic acid receptor antagonists.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Chemical and pharmaceutical bulletin

• Publication date

  2009-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1248/CPB.57.826PMID 19652407
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis and Biological Evaluation of Novel 9-Heteroaryl Substituted 7-Chloro-4,5-dihydro-4-oxo-1,2,4-triazolo [1,5-a]quinoxaline-2-carboxylates (TQX) as (R,S)-2-Amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic Acid (AMPA) Receptor Antagonists.

  2009cited by this paper
• Novel AMPA and kainate receptor antagonists containing the pyrazolo[1,5-c]quinazoline ring system: Synthesis and structure-activity relationships.

  2008cited by this paper
• Tandem 3D-QSARs approach as a valuable tool to predict binding affinity data: design of new Gly/NMDA receptor antagonists as a key study.

  2007cited by this paper
• The NMDA receptor/ion channel complex: a drug target for modulating synaptic plasticity and excitotoxicity.

  2007cited by this paper
• Competitive Gly/NMDA receptor antagonists.

  2006cited by this paper
• Structural investigation of the 7-chloro-3-hydroxy-1H-quinazoline-2,4-dione scaffold to obtain AMPA and kainate receptor selective antagonists. Synthesis, pharmacological, and molecular modeling studies.

  2006cited by this paper
• 1-Substituted pyrazolo[1,5-c]quinazolines as novel Gly/NMDA receptor antagonists: synthesis, biological evaluation, and molecular modeling study.

  2005cited by this paper
• Synthesis and pharmacological studies at the Gly/NMDA, AMPA and Kainate receptors of new oxazolo[4,5-c]quinolin-4-one derivatives bearing different substituents at position-2 and on the fused benzo ring.

  2005cited by this paper
• Ionotropic and metabotropic glutamate receptor structure and pharmacology

  2005cited by this paper
• 3-hydroxy-quinazoline-2,4-dione as a useful scaffold to obtain selective Gly/NMDA and AMPA receptor antagonists.

  2004cited by this paper
• Synthesis and biological evaluation of analogues of 7-chloro-4,5-dihydro-4- oxo-8-(1,2,4-triazol-4-yl)-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylic acid (TQX-173) as novel selective AMPA receptor antagonists.

  2004cited by this paper
• Antagonists and agonists at the glycine site of the NMDA receptor for therapeutic interventions.

  2003cited by this paper
• Glutamate receptor function in learning and memory.

  2003cited by this paper
• Synthesis and biological evaluation of a new set of pyrazolo[1,5-c]quinazoline-2-carboxylates as novel excitatory amino acid antagonists.

  2002cited by this paper
• The NMDA receptor complex: a promising target for novel antiepileptic strategies.

  2001cited by this paper
• Synthesis, ionotropic glutamate receptor binding affinity, and structure-activity relationships of a new set of 4,5-dihydro-8-heteroaryl-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates analogues of TQX-173.

  2001cited by this paper
• Synthesis of a set of ethyl 1-carbamoyl-3-oxoquinoxaline-2-carboxylates and of their constrained analogue imidazo.

  2001cited by this paper
• 7-Chloro-4,5-dihydro-8-(1,2,4-triazol-4-yl)-4-oxo-1,2,4-triazolo[1, 5-a]quinoxaline-2- carboxylates as novel highly selective AMPA receptor antagonists.

  2000cited by this paper
• Ligands for glutamate receptors: design and therapeutic prospects.

  2000cited by this paper
• Recent developments in glycine antagonists

  2000cited by this paper
• 4,5-Dihydro-1,2,4-triazolo[1,5-a]quinoxalin-4-ones: excitatory amino acid antagonists with combined glycine/NMDA and AMPA receptor affinity.

  1999cited by this paper
• Synthesis, Glycine/NMDA and AMPA Binding Activity of Some New 2,5,6‐Trioxopyrazino[1,2,3‐de]quinoxalines and of Their Restricted Analogs 2,5‐Dioxo‐ and 4,5‐Dioxoimidazo[1,5,4‐de]quinoxalines

  1999cited by this paper
• The glutamate receptor ion channels.

  1999cited by this paper
• Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications.

  1998cited by this paper
• The glycine site on the NMDA receptor: structure-activity relationships and possible therapeutic applications.

  1998cited by this paper
• Synthesis and Biological Evaluation of a Series of Quinazoline‐2‐carboxylic Acids and Quinazoline‐2,4‐diones as Glycine‐NMDA Antagonists: A Pharmacophore Model Based Approach

  1997cited by this paper
• Patent Update Central & Peripheral Nervous Systems: Glycine-site NMDA receptor antagonists: an update

  1996cited by this paper
• Review Central & Peripheral Nervous Systems: Glycine-site NMDA receptor antagonists

  1995cited by this paper
• The glycine site on the NMDA receptor: structure-activity relationships and therapeutic potential.

  1994cited by this paper
• 4-Amido-2-carboxytetrahydroquinolines. Structure-activity relationships for antagonism at the glycine site of the NMDA receptor.

  1992cited by this paper
• Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

  1973cited by this paper

• In situ generated CF3CHN2 with 3-ylideneoxindoles to access CF3-containing pyrazolo[1,5-c]quinazolines derivatives

  2024cites this paper
• Leveraging in situ N-tosylhydrazones as diazo surrogates for efficient access to pyrazolo-[1,5-c]quinazolinone derivatives.

  2024cites this paper
• The Practical Access to Fluoroalkylated Pyrazolo[1,5-c]quinazolines by Fluoroalkyl-Promoted [3 + 2] Cycloaddition Reaction.

  2023cites this paper
• Progress in Synthesis and Bioactivity Evaluation of Pyrazoloquinazolines

  2020cites this paper
• Regioselective ring expansion of 3-ylideneoxindoles with tosyldiazomethane (TsDAM) : A metal-free and greener approach for the synthesis of pyrazolo-[1,5-c]quinazolines.

  2020cites this paper
• A Protocol for the Synthesis of CF2H-Containing Pyrazolo[1,5- c]quinazolines from 3-Ylideneoxindoles and in Situ Generated CF2HCHN2.

  2018cites this paper
• A New Synthetic Route for the Synthesis of 2-Aryl/Heteroaryl Pyrazolo [1,5-C] Quinazolines

  2017cites this paper
• Copper-catalyzed [3 + 2] cycloaddition reactions: synthesis of substituted pyrazolo[1,5-c]quinazolines with N-iminoquinazolinium ylides and olefins as starting materials

  2016cites this paper
• Synthesis of 5,6-dihydropyrazolo[1,5-c]quinazolines through gold-catalyzed chemoselective bicyclization of N-propargylic sulfonylhydrazones.

  2015cites this paper
• Quinazolines: new horizons in anticonvulsant therapy.

  2014cites this paper
• Synthesis of pyrazolo[1,5-c]quinazoline derivatives through copper-catalyzed tandem reaction of 5-(2-bromoaryl)-1H-pyrazoles with carbonyl compounds and aqueous ammonia.

  2013cites this paper
• Chapter 6.2 - Six-Membered Ring Systems: Diazines and Benzo Derivatives

  2011cites this paper